JP2022547617A5 - - Google Patents

Info

Publication number
JP2022547617A5
JP2022547617A5 JP2022516442A JP2022516442A JP2022547617A5 JP 2022547617 A5 JP2022547617 A5 JP 2022547617A5 JP 2022516442 A JP2022516442 A JP 2022516442A JP 2022516442 A JP2022516442 A JP 2022516442A JP 2022547617 A5 JP2022547617 A5 JP 2022547617A5
Authority
JP
Japan
Application number
JP2022516442A
Other languages
Japanese (ja)
Other versions
JP7566889B2 (ja
JP2022547617A (ja
JPWO2021055376A5 (https=
Filing date
Publication date
Priority claimed from US16/783,268 external-priority patent/US11447468B2/en
Application filed filed Critical
Priority claimed from PCT/US2020/050924 external-priority patent/WO2021055376A1/en
Publication of JP2022547617A publication Critical patent/JP2022547617A/ja
Publication of JP2022547617A5 publication Critical patent/JP2022547617A5/ja
Publication of JPWO2021055376A5 publication Critical patent/JPWO2021055376A5/ja
Priority to JP2024173357A priority Critical patent/JP2025013344A/ja
Application granted granted Critical
Publication of JP7566889B2 publication Critical patent/JP7566889B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022516442A 2019-09-16 2020-09-15 Il-17aモジュレーターおよびその使用 Active JP7566889B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024173357A JP2025013344A (ja) 2019-09-16 2024-10-02 Il-17aモジュレーターおよびその使用

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962901249P 2019-09-16 2019-09-16
US62/901,249 2019-09-16
US16/783,268 US11447468B2 (en) 2019-02-06 2020-02-06 IL-17 ligands and uses thereof
US16/783,268 2020-02-06
PCT/US2020/016925 WO2020163554A1 (en) 2019-02-06 2020-02-06 Il-17a modulators and uses thereof
USPCT/US2020/016925 2020-02-06
US202063061719P 2020-08-05 2020-08-05
US63/061,719 2020-08-05
PCT/US2020/050924 WO2021055376A1 (en) 2019-09-16 2020-09-15 Il-17a modulators and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024173357A Division JP2025013344A (ja) 2019-09-16 2024-10-02 Il-17aモジュレーターおよびその使用

Publications (4)

Publication Number Publication Date
JP2022547617A JP2022547617A (ja) 2022-11-14
JP2022547617A5 true JP2022547617A5 (https=) 2024-01-05
JPWO2021055376A5 JPWO2021055376A5 (https=) 2024-01-05
JP7566889B2 JP7566889B2 (ja) 2024-10-15

Family

ID=74884681

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022516442A Active JP7566889B2 (ja) 2019-09-16 2020-09-15 Il-17aモジュレーターおよびその使用
JP2024173357A Pending JP2025013344A (ja) 2019-09-16 2024-10-02 Il-17aモジュレーターおよびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024173357A Pending JP2025013344A (ja) 2019-09-16 2024-10-02 Il-17aモジュレーターおよびその使用

Country Status (12)

Country Link
US (4) US11274094B2 (https=)
EP (1) EP4031534A1 (https=)
JP (2) JP7566889B2 (https=)
KR (1) KR20220101075A (https=)
CN (1) CN115103835B (https=)
AU (2) AU2020348685B2 (https=)
BR (1) BR112022004802A2 (https=)
CA (1) CA3154608A1 (https=)
IL (1) IL291345B2 (https=)
MX (1) MX2022003166A (https=)
WO (1) WO2021055376A1 (https=)
ZA (1) ZA202203580B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI839461B (zh) 2019-02-06 2024-04-21 美商戴斯阿爾法股份有限公司 Il-17a調節物及其用途
IL291345B2 (en) 2019-09-16 2024-04-01 Dice Alpha Inc Il-17a modulators and uses thereof
MX2024000504A (es) * 2021-07-09 2024-04-05 Dice Alpha Inc Moduladores de il-17a basados en fenilacetamida y usos de los mismos.
WO2023025783A1 (en) 2021-08-23 2023-03-02 Leo Pharma A/S Small molecule modulators of il-17
CN113896712B (zh) * 2021-11-12 2024-04-09 华东理工大学 含环类氨基酸的二酰胺类化合物
WO2023111181A1 (en) 2021-12-16 2023-06-22 Leo Pharma A/S Small molecule modulators of il-17
US20250177383A1 (en) 2022-02-25 2025-06-05 Dice Alpha, Inc. Di-cyclopropyl based il-17a modulators and uses thereof
WO2023166172A1 (en) 2022-03-04 2023-09-07 Leo Pharma A/S Small molecule modulators of il-17
TW202430165A (zh) 2022-12-02 2024-08-01 丹麥商理奧藥品公司 Il-17之小分子調節劑
WO2024208228A1 (en) * 2023-04-03 2024-10-10 Nuphase Therapeutics (Hangzhou) Limited., Co. Novel compounds, compositions comprising the same and uses thereof
CN121079298A (zh) * 2023-05-12 2025-12-05 上海翰森生物医药科技有限公司 噻唑类衍生物抑制剂、其制备方法和应用
EP4713318A2 (en) * 2023-05-18 2026-03-25 Ascletis Pharma (China) Co., Limited Small molecule modulators of il-17a, methods of making and methods of using thereof
WO2025077732A1 (en) * 2023-10-09 2025-04-17 Shenzhen Ionova Life Science Co., Ltd. Novel interleukin-17 inhibtors
WO2025080986A1 (en) * 2023-10-13 2025-04-17 Quantx Biosciences Us, Inc. Amide compounds
WO2025131062A1 (zh) * 2023-12-21 2025-06-26 江苏恒瑞医药股份有限公司 烯烃类化合物、其制备方法及其在医药上的应用
WO2025201532A1 (en) * 2024-03-28 2025-10-02 Nuphase Therapeutics (Shanghai) Limited., Co. Novel pegylation compounds, compositions comprising the same and uses thereof
WO2025201533A1 (en) * 2024-03-28 2025-10-02 Nuphase Therapeutics (Shanghai) Limited., Co. Novel acidic compounds, compositions comprising the same and uses thereof
WO2025209395A1 (en) * 2024-04-03 2025-10-09 Innocare Pharma Inc. Il-17 modulators and used thereof
WO2026021539A1 (zh) * 2024-07-24 2026-01-29 深圳信立泰药业股份有限公司 双环il-17a/f抑制剂及其制备方法与应用
WO2026040422A1 (en) * 2024-08-19 2026-02-26 Shenzhen Ionova Life Science Co., Ltd. Novel interleukin-17 inhibtors
WO2026077367A1 (en) * 2024-10-09 2026-04-16 Foshan Ionova Biotherapeutics Co., Inc. Novel interleukin-17 inhibtors

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3710795A (en) 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US4044126A (en) 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
GB1429184A (en) 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
USRE28819E (en) 1972-12-08 1976-05-18 Syntex (U.S.A.) Inc. Dialkylated glycol compositions and medicament preparations containing same
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4328245A (en) 1981-02-13 1982-05-04 Syntex (U.S.A.) Inc. Carbonate diester solutions of PGE-type compounds
US4410545A (en) 1981-02-13 1983-10-18 Syntex (U.S.A.) Inc. Carbonate diester solutions of PGE-type compounds
US4358603A (en) 1981-04-16 1982-11-09 Syntex (U.S.A.) Inc. Acetal stabilized prostaglandin compositions
US4409239A (en) 1982-01-21 1983-10-11 Syntex (U.S.A.) Inc. Propylene glycol diester solutions of PGE-type compounds
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
HU196714B (en) 1984-10-04 1989-01-30 Monsanto Co Process for producing non-aqueous composition comprising somatotropin
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US5033252A (en) 1987-12-23 1991-07-23 Entravision, Inc. Method of packaging and sterilizing a pharmaceutical product
US5052558A (en) 1987-12-23 1991-10-01 Entravision, Inc. Packaged pharmaceutical product
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
PH30995A (en) 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
IT1246382B (it) 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5543390A (en) 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Covalent microparticle-drug conjugates for biological targeting
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US6010715A (en) 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
US6024975A (en) 1992-04-08 2000-02-15 Americare International Diagnostics, Inc. Method of transdermally administering high molecular weight drugs with a polymer skin enhancer
US5323907A (en) 1992-06-23 1994-06-28 Multi-Comp, Inc. Child resistant package assembly for dispensing pharmaceutical medications
TW333456B (en) 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US5985307A (en) 1993-04-14 1999-11-16 Emory University Device and method for non-occlusive localized drug delivery
US5523092A (en) 1993-04-14 1996-06-04 Emory University Device for local drug delivery and methods for using the same
US6087324A (en) 1993-06-24 2000-07-11 Takeda Chemical Industries, Ltd. Sustained-release preparation
US6004534A (en) 1993-07-23 1999-12-21 Massachusetts Institute Of Technology Targeted polymerized liposomes for improved drug delivery
CN1087725C (zh) 1994-03-25 2002-07-17 同位素技术有限公司 用氘代方法增强药物效果
US6334997B1 (en) 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US5759542A (en) 1994-08-05 1998-06-02 New England Deaconess Hospital Corporation Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases
US5660854A (en) 1994-11-28 1997-08-26 Haynes; Duncan H Drug releasing surgical implant or dressing material
US5983134A (en) 1995-04-23 1999-11-09 Electromagnetic Bracing Systems Inc. Electrophoretic cuff apparatus drug delivery system
US6316652B1 (en) 1995-06-06 2001-11-13 Kosta Steliou Drug mitochondrial targeting agents
AU6242096A (en) 1995-06-27 1997-01-30 Takeda Chemical Industries Ltd. Method of producing sustained-release preparation
US6167301A (en) 1995-08-29 2000-12-26 Flower; Ronald J. Iontophoretic drug delivery device having high-efficiency DC-to-DC energy conversion circuit
TW448055B (en) 1995-09-04 2001-08-01 Takeda Chemical Industries Ltd Method of production of sustained-release preparation
JP2909418B2 (ja) 1995-09-18 1999-06-23 株式会社資生堂 薬物の遅延放出型マイクロスフイア
US6039975A (en) 1995-10-17 2000-03-21 Hoffman-La Roche Inc. Colon targeted delivery system
US5980945A (en) 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
TW345603B (en) 1996-05-29 1998-11-21 Gmundner Fertigteile Gmbh A noise control device for tracks
US6264970B1 (en) 1996-06-26 2001-07-24 Takeda Chemical Industries, Ltd. Sustained-release preparation
US6419961B1 (en) 1996-08-29 2002-07-16 Takeda Chemical Industries, Ltd. Sustained release microcapsules of a bioactive substance and a biodegradable polymer
US5985317A (en) 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
HUP0000116A3 (en) 1996-10-01 2000-08-28 Stanford Res Inst Int Taste-masked microcapsule compositions and methods of manufacture
CA2217134A1 (en) 1996-10-09 1998-04-09 Sumitomo Pharmaceuticals Co., Ltd. Sustained release formulation
DE69730093T2 (de) 1996-10-31 2006-07-20 Takeda Pharmaceutical Co. Ltd. Zubereitung mit verzögerter Freisetzung
US6131570A (en) 1998-06-30 2000-10-17 Aradigm Corporation Temperature controlling device for aerosol drug delivery
WO1998027980A2 (en) 1996-12-20 1998-07-02 Takeda Chemical Industries, Ltd. Method of producing a sustained-release preparation
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
US5860957A (en) 1997-02-07 1999-01-19 Sarcos, Inc. Multipathway electronically-controlled drug delivery system
US6120751A (en) 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US6060082A (en) 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
WO1999021537A1 (fr) 1997-10-28 1999-05-06 Bando Chemical Industries, Ltd. Feuille de timbre cutane et procede de production d'une feuille de base pour timbre
CA2316273A1 (en) 1998-01-16 1999-07-22 Takeda Chemical Industries, Ltd. Sustained-release composition, method of its production and use thereof
US6613358B2 (en) 1998-03-18 2003-09-02 Theodore W. Randolph Sustained-release composition including amorphous polymer
US6048736A (en) 1998-04-29 2000-04-11 Kosak; Kenneth M. Cyclodextrin polymers for carrying and releasing drugs
KR19990085365A (ko) 1998-05-16 1999-12-06 허영섭 지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6271359B1 (en) 1999-04-14 2001-08-07 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
US6256533B1 (en) 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
US6261595B1 (en) 2000-02-29 2001-07-17 Zars, Inc. Transdermal drug patch with attached pocket for controlled heating device
US20060270730A1 (en) 2003-08-07 2006-11-30 Andreas Katopodis Histone deacetylase inhibitors as immunosuppressants
CA2538237A1 (en) 2003-09-10 2005-03-24 Map Pharmaceuticals, Inc. Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
EP2403531A4 (en) * 2009-03-05 2013-02-27 Abbott Lab IL-17 BINDING PROTEINS
US9284283B2 (en) * 2012-02-02 2016-03-15 Ensemble Therapeutics Corporation Macrocyclic compounds for modulating IL-17
WO2014066726A2 (en) * 2012-10-26 2014-05-01 Ensemble Therapeutics Corporation Compounds for modulating il-17
ES2950424T3 (es) * 2013-07-03 2023-10-09 Takeda Pharmaceuticals Co Compuesto de amida
UA117941C2 (uk) * 2013-12-05 2018-10-25 Лід Фарма Холдінг Б.В. МОДУЛЯТОРИ ROR-ГAMMA (RORγ)
EP3101006A1 (en) * 2015-06-05 2016-12-07 Lead Pharma Cel Models IP B.V. Ror gamma (rory) modulators
WO2018030550A1 (en) * 2016-08-09 2018-02-15 Takeda Pharmaceutical Company Limited Heterocyclic compounds with an ror(gamma)t modulating activity
EP3523279A1 (en) * 2016-10-10 2019-08-14 Bristol-Myers Squibb Company Tricyclic sulfones as ror gamma modulators
WO2019163945A1 (ja) * 2018-02-22 2019-08-29 学校法人東海大学 Il-17a活性阻害剤およびその用途
GB201820166D0 (en) 2018-12-11 2019-01-23 Ucb Biopharma Sprl Therapeutic agents
TWI839461B (zh) 2019-02-06 2024-04-21 美商戴斯阿爾法股份有限公司 Il-17a調節物及其用途
IL291345B2 (en) 2019-09-16 2024-04-01 Dice Alpha Inc Il-17a modulators and uses thereof

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
JP2022547617A5 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
CH718816A4 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)